HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
1 clinical trials · Condition
◉ Watch HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy (NCT05560308) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-30 |
Track HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy automatically
Every clearance here is in the API, with alerts when new ones post.